MAM
HARP
MPM Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-313,136
| Closed | -$3.56M | – | 7 |
|
|
2023
Q4 | $3.56M | Hold |
313,136
| – | – | 1.75% | 7 |
|
|
2023
Q3 | $1.26M | Sell |
313,136
-2,818,252
| -90% | -$11.4M | 0.68% | 7 |
|
|
2023
Q2 | $2.22M | Hold |
3,131,388
| – | – | 1.09% | 7 |
|
|
2023
Q1 | $2.33M | Hold |
3,131,388
| – | – | 0.97% | 8 |
|
|
2022
Q4 | $2.27M | Hold |
3,131,388
| – | – | 0.95% | 8 |
|
|
2022
Q3 | $3.04M | Hold |
3,131,388
| – | – | 1.16% | 8 |
|
|
2022
Q2 | $5.98M | Hold |
3,131,388
| – | – | 2.52% | 8 |
|
|
2022
Q1 | $15.6M | Hold |
3,131,388
| – | – | 5.32% | 7 |
|
|
2021
Q4 | $23.6M | Hold |
3,131,388
| – | – | 5.11% | 7 |
|
|
2021
Q3 | $24.7M | Buy |
3,131,388
+1,121
| +0% | +$8.86K | 5.73% | 8 |
|
|
2021
Q2 | $43.4M | Sell |
3,130,267
-108,039
| -3% | -$1.5M | 8.07% | 6 |
|
|
2021
Q1 | $67.7M | Sell |
3,238,306
-1,286,119
| -28% | -$26.9M | 13.09% | 5 |
|
|
2020
Q4 | $75.2M | Hold |
4,524,425
| – | – | 10.63% | 6 |
|
|
2020
Q3 | $76.9M | Hold |
4,524,425
| – | – | 14.33% | 5 |
|
|
2020
Q2 | $75.1M | Hold |
4,524,425
| – | – | 22.35% | 2 |
|
|
2020
Q1 | $52.4M | Hold |
4,524,425
| – | – | 31.87% | 1 |
|
|
2019
Q4 | $66.9M | Hold |
4,524,425
| – | – | 29.45% | 1 |
|
|
2019
Q3 | $61.8M | Hold |
4,524,425
| – | – | 26.45% | 2 |
|
|
2019
Q2 | $58.8M | Hold |
4,524,425
| – | – | 23.77% | 2 |
|
|
2019
Q1 | $42.8M | Buy |
+4,524,425
| New | +$42.8M | 17.67% | 3 |
|